ArticleOncotarget2016

Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.

Hsin-Lin Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.